EXOBREATH LIMITED

Executive Summary

EXOBREATH LIMITED is a dormant private limited company with minimal financial activity and nominal net assets, reflecting its status as a non-trading entity since incorporation. The company is compliant with filing requirements and has stable governance but currently shows no signs of operational or financial growth. To enhance its financial health, it is recommended to initiate business activities, secure adequate capital, and maintain strong financial and governance controls.

EXOBREATH LIMITED - Analysis Report

Company Number: 13834770

Analysis Date: 2025-07-29 13:32 UTC

Financial Health Assessment for EXOBREATH LIMITED

---

1. Financial Health Score: C

Explanation:
EXOBREATH LIMITED is currently a dormant private limited company with minimal financial activity and very limited financial data available. As such, it neither shows signs of financial distress nor active business growth. The score "C" reflects a neutral position—no immediate concerns but also no evidence of financial vitality, typical for a startup or holding entity in dormancy.

---

2. Key Vital Signs

Metric	Value	Interpretation
Company Status	Active, Dormant	The company is legally active but has declared dormant status, indicating no trading activity.
Net Assets	£2	Extremely low net assets, consistent with dormancy and minimal capital investment.
Shareholders’ Funds	£2	Reflects nominal issued share capital only; no retained earnings or reserves.
Filing Compliance	Up to date	Accounts and confirmation statements are filed on time; no overdue filings or penalties.
Directors and PSCs	Two directors/PSCs with equal control	Stable governance structure with clear control; no disqualifications or governance issues.
Industry Classification (SIC)	Manufacture of medical and dental instruments and supplies	Sector with high regulation and capital needs, but currently no trading activity reported.

---

3. Diagnosis: Financial and Operational Health

• Dormant Status: The company has been dormant since incorporation in 2022, meaning it has had no significant financial transactions or trading. This is reflected by the constant minimal net assets (£2) representing only the nominal share capital.

• Cash Flow and Liquidity: As a dormant entity, there are no operating cash flows or working capital movements. This absence of activity means the company is not generating revenue or incurring expenses, so traditional liquidity and solvency metrics do not apply.

• Capital Structure: The share capital is minimal, with no retained earnings or reserves. This is typical for a startup or holding entity that has not yet commenced operations or sought investment.

• Governance and Compliance: The directors are current and appear to have a stable governance framework. All statutory filings are current, with no overdue returns or accounts, indicating good compliance with regulatory requirements.

• Industry Considerations: The SIC code indicates the company is positioned in a highly regulated and potentially capital-intensive sector (medical and dental instruments). Dormancy suggests it is in a preparatory phase or awaiting business development before active operations.

• Risk Indicators: No signs of financial distress, insolvency, or governance issues. The main “symptom” is the lack of trading activity, which may limit the company’s ability to build financial strength or market presence in the short term.

---

4. Recommendations: Path to Financial Wellness

• Commence Trading or Business Activities: To improve financial health, the company should plan and initiate commercial operations aligned with its industry. This will generate revenue, build assets, and create working capital.

• Capital Injection: Consider raising additional equity or securing financing to support the start-up phase, product development, or market entry. A higher capital base will improve net assets and financial resilience.

• Financial Planning: Develop a robust business plan and financial forecasts to transition from dormancy to active trading. This includes budgeting for operating expenses, expected revenues, and investment needs.

• Maintain Compliance: Continue timely filing of accounts and confirmation statements to avoid penalties and maintain good standing with Companies House.

• Governance Oversight: Directors should regularly review the company’s strategic direction and financial position once operations begin, ensuring early detection of any financial symptoms such as cash flow shortages or increasing liabilities.

---